Skip to main content

Landmark Study Reveals Significant Progress in SBA 7(a) Lending to Black Entrepreneurs

A groundbreaking new study reveals a remarkable increase in SBA 7(a) loans, both in count and total value, to Black or African American entrepreneurs from 2017 to 2023. The data underlines significant strides in fostering greater small business lending equity. We predict 7(a) lending to African American firms will reach $1 billion in 2023, up from $599 million in 2017.

In 2017, a modest 3.86% of SBA 7(a) loans were disbursed to Black business owners. By 2023, this figure had surged to an encouraging 7.76%. In parallel, the percentage of total loan value received by Black entrepreneurs climbed from 2.36% to 4.41% over the same period.

"We are heartened by these findings," says William Michael Cunningham, CEO of Creative Investment Research, "which signal the tangible progress we've been striving for. However, they also underscore the critical work that remains in order to achieve true equity in small business financing."

While the study's results clearly illustrate a trend towards greater inclusivity, they also highlight the need for continuous and focused efforts. The gap between the proportion of the Black population in the U.S and the percentage of total loan dollars they receive serves as a stark reminder of the ongoing challenges.

The team behind the study suggests several measures to sustain and accelerate this upward trajectory. These include increased outreach in Black communities, financial literacy programs (see our Udemy class: How to Finance a Black Women-owned Business), policies that eliminate lending biases, leveraging fintech solutions, enactment of supportive government policies, and bolstering the capabilities of Black-owned banks.

See: https://www.prlog.org/12969810-landmark-study-reveals-significant-progress-in-sba-7a-lending-to-black-entrepreneurs.html

Popular posts from this blog

Maternal Health Financing Facility for Black Women: A Solution to an Urgent Problem

Maternal mortality is a significant issue in the United States, with Black women disproportionately affected. Research conducted by the Centers for Disease Control and Prevention (CDC) has shown that Black women are more likely to die from pregnancy-related causes than their white counterparts. However, the issue is not new, and despite the increasing amount of data available, the disparities have remained unaddressed for far too long.  Creative Investment Research (CIR) is among the organizations that believe there is a solution to the problem. Through our proposed impact investing vehicle , the Maternal Health Financing Facility for Black Women (MHFFBW), we aim to tackle the mortality gap and support Black women during childbirth, which will, in turn, benefit their communities. The Facility, based on legally binding financing agreements containing terms and conditions that direct resources to individuals and institutions capable of addressing supply-side conditions at the heart...

Projected Impact of Gun Laws on Corporate Profits in Texas

More Fortune 500 companies are located in Texas than in any other state. Texas successfully used low taxes and minimal regulations as bait to recruit companies like Tesla and Oracle. The state promoted these “advantages” in ads highlighting their “free-market” environment and criticizing the "tax and spend policies of liberal leadership" in Democrat-run states. Four million people migrated to Texas over the past ten years. Our economic models predict a reversal, however. State of Texas corporations on the Fortune 1000 list generate $2.2 trillion in revenue, $158 billion in profit. They have a market value of $3.8 trillion and employ 2.5 million people nationwide. We continue to believe this increased corporate presence in Texas imposes a tax on the nation as a whole. Texas allows anyone 21 or older to carry handguns without training or licenses, and maintains lower gun purchase age limits. Beyond the recent abortion bill, which allows people to sue those who "aid and abe...

SUMMARY: THE INFLATION REDUCTION ACT OF 2022

The Inflation Reduction Act of 2022 (IRA) is a law passed by the 117th United States Congress in August 2022. It "includes a first-time provision that would allow the U.S. Department of Health and Human Services to negotiate prices of certain prescription drugs in Medicare and Medicaid. Savings would be generated by requiring drug manufacturers to pay a rebate for drugs whose prices increase faster than inflation under Medicare, and would create several reforms in the Medicare drug program, also known as Part D, including a cap on out-of-pocket drug spending for seniors beginning in 2025. It also extends by three years the expanded and enhanced Affordable Care Act tax credit ahead of planned premium increases set to take effect in 2023." We estimate the impact on the African American community to be significant, on the order of 8% of the total. (For a detailed analysis, email info@creativeinvest.com). The law's climate provisions consist of "subsidies for energy that...